Clincosm LogoSign in Get a demo

carcinoma, squamous cell

Showing 1 - 25 of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oncogenic Drivers and Somatic Evolution in the Oral Mucosa

Not yet recruiting
  • Carcinoma, Squamous Cell
  • Oral cytobrush
  • Bougival, France
  • +14 more
Oct 16, 2023

Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)

Not yet recruiting
  • Cancer
  • +6 more
  • KB707
  • (no location specified)
Jul 24, 2023

Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, Carcinoma, Basal Cell Trial in Canada (Nicotinamide, Placebo)

Not yet recruiting
  • Non-melanoma Skin Cancer
  • +3 more
  • Calgary, Alberta, Canada
  • +7 more
Jul 13, 2023

Disease-free Survival of High-risk Head-neck Cutaneous Squamous

Active, not recruiting
  • Carcinoma, Squamous Cell
  • +5 more
  • Treatment
  • Maastricht, Netherlands
  • +1 more
Apr 26, 2023

Carcinoma, Squamous Cell Trial in Worldwide (Pembrolizumab 400 mg, Placebo)

Recruiting
  • Carcinoma, Squamous Cell
  • Pembrolizumab 400 mg
  • Placebo
  • Mobile, Alabama
  • +170 more
Jan 19, 2023

Carcinoma, Squamous Cell Trial in Pittsburgh (5-fluorouracil, Imiquimod 5% cream)

Recruiting
  • Carcinoma, Squamous Cell
  • Pittsburgh, Pennsylvania
    St. Margaret Hospital Dermatology
Oct 6, 2022

Mouth Tumors, Carcinoma, Squamous Cell Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Mouth Neoplasms
  • Carcinoma, Squamous Cell
  • TPF induction chemotherapy
  • +2 more
  • Shanghai, Shanghai, China
    Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong
Oct 5, 2022

Mouth Tumors, Carcinoma, Squamous Cell Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Mouth Neoplasms
  • Carcinoma, Squamous Cell
  • TPF induction chemotherapy
  • +2 more
  • Shanghai, Shanghai, China
    Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong
Oct 5, 2022

Mouth Tumors, Carcinoma, Squamous Cell Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Mouth Neoplasms
  • Carcinoma, Squamous Cell
  • TPF group
  • +2 more
  • Shanghai, Shanghai, China
    Ninth People's Hospital, Shanghai Jiao Tong University School of
Oct 5, 2022

Progression of Invasive Squamous Cell Carcinoma

Recruiting
  • Carcinoma, Squamous Cell
  • +10 more
  • DNA Extraction
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 27, 2022

Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)

Active, not recruiting
  • Laryngeal Cancer Stage II
  • +3 more
  • Amsterdam, Netherlands
    The Netherlands Cancer Institute
Sep 27, 2022

Carcinoma, Squamous Cell, Head and Neck Tumor, Cervical Tumor Trial in Southampton (BNT113)

Recruiting
  • Carcinoma, Squamous Cell
  • +3 more
  • Southampton, Hampshire, United Kingdom
    Univeristy Hospitals Southampton NHS Foundation Trust
May 17, 2022

Head Neck Cancer, Carcinoma, Squamous Cell, Tumors, Oral Trial in Chicago, Dallas (Intensity Modulated Radiation Therapy, chemo)

Completed
Has Results
  • Head and Neck Cancer
  • +3 more
  • Chicago, Illinois
  • +1 more
Feb 16, 2022

Circulating Tumor DNA in Locally Advanced Head and Neck Squamous

Suspended
  • Head and Neck Neoplasm
  • Carcinoma, Squamous Cell
  • Blood and tumor samples
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Feb 24, 2022

Carcinoma, Squamous Cell Trial in United States (VTX-2337, Nivolumab)

Completed
  • Carcinoma, Squamous Cell
  • Birmingham, Alabama
  • +6 more
Feb 23, 2022

Esophageal Squamous Cell Carcinoma, Esophageal Tumors, Esophageal Diseases Trial (Anlotinib HCl, TQB2450)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • +10 more
  • (no location specified)
Feb 19, 2022

Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, Carcinoma, Basal Cell Trial in Toronto (Nicotinamide, Placebo oral capsule)

Active, not recruiting
  • Non-melanoma Skin Cancer
  • +2 more
  • Toronto, Ontario, Canada
    Toronto General Hospital, University Health Network
Feb 9, 2022

Carcinoma, Squamous Cell, Head and Neck Tumors, Oropharyngeal Tumors Trial in United States (radiation, drug, procedure)

Active, not recruiting
  • Carcinoma, Squamous Cell
  • +2 more
  • Intensity Modulated Radiotherapy (IMRT) - deintensified
  • +4 more
  • Gainesville, Florida
  • +3 more
Jan 25, 2022

Head and Neck Tumors, Carcinoma, Squamous Cell Trial in Netherlands (standard dose prescription, FDG-PET guided gradient dose

Active, not recruiting
  • Head and Neck Neoplasms
  • Carcinoma, Squamous Cell
  • standard dose prescription
  • FDG-PET guided gradient dose prescription
  • Amsterdam, Netherlands
  • +4 more
Jan 25, 2022

Carcinoma, Squamous Cell, Head and Neck Tumors, Oropharyngeal Tumors Trial in United States (radiation, drug, procedure)

Active, not recruiting
Has Results
  • Carcinoma, Squamous Cell
  • +2 more
  • Intensity Modulated Radiotherapy (IMRT)
  • +2 more
  • Gainesville, Florida
  • +4 more
Dec 15, 2021

Carcinoma, Squamous Cell, Head and Neck Tumors, Oropharyngeal Tumors Trial in United States (radiation, drug, procedure)

Completed
Has Results
  • Carcinoma, Squamous Cell
  • +2 more
  • Intensity Modulated Radiotherapy (IMRT)
  • +2 more
  • Colorado Springs, Colorado
  • +4 more
Dec 7, 2021

Carcinoma, Squamous Cell, Head Neck Cancer Trial in Lexington (Cisplatin, XRT)

Recruiting
  • Carcinoma, Squamous Cell
  • Head and Neck Cancer
  • Lexington, Kentucky
    University of Kentucky
Nov 17, 2021

NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Aberdeen, United Kingdom
  • +24 more
Nov 2, 2021

Carcinoma, Squamous Cell Trial in Syracuse (drug, biological, radiation)

Completed
  • Carcinoma, Squamous Cell
  • paclitaxel poliglumex
  • +2 more
  • Syracuse, New York
    SUNY Upstate Medical University
Oct 29, 2021

Carcinoma, Squamous Cell, Carcinoma, Squamous Cell of Head and Neck Trial in New York (Intraarterial Cetxuimab (Erbitux))

Terminated
  • Carcinoma, Squamous Cell
  • Carcinoma, Squamous Cell of Head and Neck
  • Intraarterial Cetxuimab (Erbitux)
  • New York, New York
    Lenox Hill Hospital
Oct 27, 2021